Table 2.
Hazard ratios of TG levels for T2DM in the Tianjin General Hospital Cohort and in the CHARLS
| Tianjin General Hospital Cohort HR (95% CI)† |
CHARLS HR (95% CI)† |
P-value* | ||
|---|---|---|---|---|
| Tianjin General Hospital Cohort | CHARLS | |||
| logTG | 2.58 (1.87–3.57) | 3.94 (2.64–5.87) | < 0.001 | 0.001 |
| Female | 0.69 (0.56–0.84) | 0.81 (0.65–1.00) | < 0.001 | 0.046 |
| Age (years) | 1.026 (1.02–1.03) | 1.02 (1.00–1.03) | < 0.001 | 0.005 |
| BMI (kg/m2) | 1.11 (1.09–1.14) | 1.10 (1.07–1.13) | < 0.001 | < 0.001 |
| Hypertension | 1.88 (1.59–2.22) | 1.37 (1.11–1.69) | < 0.001 | 0.004 |
| Hyperuricemia | 1.34 (1.10–1.63) | 0.64 (0.42–0.96) | < 0.001 | 0.033 |
TG plasma triglyceride level, BMI body mass index
*P < 0.05 was considered statistically significant
†Each time the value of hazard ratios changes by one unit, the risk doubles